DABRAFENIB

Clinical trials for DABRAFENIB explained in plain language.

Never miss a new study

Get alerted when new DABRAFENIB trials appear

Sign up with your email to follow new studies for DABRAFENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New cocktail aims to outsmart deadly colorectal cancer

Disease control Recruiting now

This study tests a combination of four drugs (sintilimab, ipilimumab, cetuximab, and dabrafenib) in people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable. The goal is to see if this mix can shrink tumors or slow the …

Matched conditions: DABRAFENIB

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 05, 2026 11:54 UTC

DABRAFENIB

Get alerted when new DABRAFENIB trials appear

New cocktail aims to outsmart deadly colorectal cancer